Geolab

Geolab Indústria Farmacêutica is a prominent pharmaceutical company based in Brazil, established in 1999. It holds the 15th position among pharmaceutical corporations nationwide. The company specializes in the production of a diverse portfolio, encompassing both generic medications and herbal remedies. Geolab operates under stringent regulatory compliance, adhering to the high standards set by Anvisa, the Brazilian Health Regulatory Agency. This commitment ensures the quality and safety of its healthcare solutions.

With a workforce ranging from 1,000 - 5,000 employees, Geolab demonstrates significant operational capacity across its 4 locations. The company is dedicated to fostering sustainability and social responsibility, integrating these principles into its business practices and pursuing relevant certifications. Its operational framework supports both business-to-business (B2B) and business-to-consumer (B2C) markets, catering to healthcare providers and individuals alike. Meet Geolab's team to understand the expertise driving its initiatives.

Geolab generates substantial revenue, reported at $160.2M, underscoring its market presence and economic contribution. The company's strategic focus on delivering effective and innovative healthcare solutions positions it as a key player in the South American market, particularly within Brazil. Its product offerings are designed to meet the evolving needs of healthcare professionals and consumers seeking reliable pharmaceutical products. The company's commitment to quality and ethical practices solidifies its reputation in the competitive healthcare sector.